At a glance
ClinicalIndex Comparison RecordN/ACompleted· 120 enrolled
Drug / intervention
Patients using Wilate as standard of careother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease
In Brief
An observational study evaluating Patients using Wilate as standard of care for Von Willebrand Disease. Completed, enrolled 120 participants across 24 sites in 10 countries.
Detailed Summary
This is an observational study, hence there is no study hypothesis
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsVon Willebrand Disease
CountriesArgentina, Canada, Czechia, Germany, Portugal, Spain, Sweden, United Kingdom, United States, Uruguay
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMay 2012
Enrollment StartOct 2012
Primary CompletionApr 2018
TodayJul 2026
First PostedMay 21, 2012
Enrollment StartOct 1, 2012
Primary CompletionApr 1, 2018
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 14.1 years ago
Interventions
Patients using Wilate as standard of careother
Patients with von Willebrand Disease using Wilate for a period of 2 years.